Literature DB >> 19871558

TYPE-SPECIFIC PROTECTION AND IMMUNITY FOLLOWING INTRANASAL INOCULATION OF MONKEYS WITH GROUP A HEMOLYTIC STREPTOCOCCI.

R F Watson1, S Rothbard, H F Swift.   

Abstract

1. Nasopharyngeal carrier states of several weeks to several months duration were induced in the Macaca mulatta by the intranasal inoculation with matt strains of group A streptococci. 2. Following such a successful inoculation with a particular type of group A streptococcus, the animal was usually resistant to reimplantation with that same type for several months to a year or more, although reimplantation with a heterologous type could generally be easily effected. 3. This resistance was shown to be closely correlated with the antibodies directed toward the type-specific M antigen, not toward the T antigen of the strains employed. 4. A majority (83.8 per cent) of the animals in which intranasal inoculation was followed by successful implantation developed significant increases in the antistreptolysin O titres of their sera; and in a limited number of instances, type-specific agglutinins and bacteriostatic antibodies were demonstrable in the animals' sera following successful implantation. 5. Nasopharyngeal carrier states could not be induced with the glossy, avirulent variants of group A streptococci; these animals, moreover, failed to show antibody responses and were susceptible to implantation with the matt variants of the homologous glossy strains. 6. The findings are in accord with the known facts regarding immunity to group A streptococci gained through experiments on rodents; and the possible relationship of these observations to the problem of type-specific immunity in human beings is discussed.

Entities:  

Year:  1946        PMID: 19871558      PMCID: PMC2135656     

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

1.  FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI. THE DEVELOPMENT OF RESISTANCE TO FIBRINOLYSIS FOLLOWING ACUTE HEMOLYTIC STREPTOCOCCUS INFECTIONS.

Authors:  W S Tillett; L B Edwards; R L Garner
Journal:  J Clin Invest       Date:  1934-01       Impact factor: 14.808

2.  STUDIES OF HEMOLYTIC STREPTOCOCCAL INFECTION. III. THE CHARACTERISTICS OF THE HEMOLYTIC STREPTOCOCCI ISOLATED FROM PATIENTS WITH ERYSIPELAS.

Authors:  C S Keefer; W W Spink
Journal:  J Clin Invest       Date:  1937-01       Impact factor: 14.808

3.  The Bacteriology of Recently Inflicted Wounds with Special Reference to the Haemolytic Streptococci and Staphylococci.

Authors:  R Hare; R E Willits
Journal:  Can Med Assoc J       Date:  1942-01       Impact factor: 8.262

4.  THE ANTIGENIC COMPLEX OF STREPTOCOCCUS HAEMOLYTICUS : I. DEMONSTRATION OF A TYPE-SPECIFIC SUBSTANCE IN EXTRACTS OF STREPTOCOCCUS HAEMOLYTICUS.

Authors:  R C Lancefield
Journal:  J Exp Med       Date:  1928-01-01       Impact factor: 14.307

5.  VARYING HEMOLYTIC AND CONSTANT COMBINING CAPACITY OF STREPTOLYSINS; INFLUENCE ON TESTING FOR ANTISTREPTOLYSINS.

Authors:  B E Hodge; H F Swift
Journal:  J Exp Med       Date:  1933-08-31       Impact factor: 14.307

6.  ANTIGENIC STREPTOCOCCAL HEMOLYSIN.

Authors:  E W Todd
Journal:  J Exp Med       Date:  1932-01-31       Impact factor: 14.307

7.  TYPING GROUP A HEMOLYTIC STREPTOCOCCI BY M PRECIPITIN REACTIONS IN CAPILLARY PIPETTES.

Authors:  H F Swift; A T Wilson; R C Lancefield
Journal:  J Exp Med       Date:  1943-08-01       Impact factor: 14.307

8.  TYPE-SPECIFIC ANTIGENS, M AND T, OF MATT AND GLOSSY VARIANTS OF GROUP A HEMOLYTIC STREPTOCOCCI.

Authors:  R C Lancefield
Journal:  J Exp Med       Date:  1940-03-31       Impact factor: 14.307

9.  ANTIGENIC PROPERTIES OF THE TYPE-SPECIFIC SUBSTANCE DERIVED FROM GROUP A HEMOLYTIC STREPTOCOCCI.

Authors:  G K Hirst; R C Lancefield
Journal:  J Exp Med       Date:  1939-02-28       Impact factor: 14.307

10.  ANTIGENIC DIFFERENCES BETWEEN MATT HEMOLYTIC STREPTOCOCCI AND THEIR GLOSSY VARIANTS.

Authors:  R C Lancefield; E W Todd
Journal:  J Exp Med       Date:  1928-11-30       Impact factor: 14.307

View more
  10 in total

1.  Studies on the bacteriophages of hemolytic streptococci. II. Antigens released from the streptococcal cell wall by a phage-associated lysin.

Authors:  R M KRAUSE
Journal:  J Exp Med       Date:  1958-12-01       Impact factor: 14.307

Review 2.  Tissue tropisms in group A streptococcal infections.

Authors:  Debra E Bessen; Sergio Lizano
Journal:  Future Microbiol       Date:  2010-04       Impact factor: 3.165

3.  Streptococcus pyogenes genes that promote pharyngitis in primates.

Authors:  Luchang Zhu; Randall J Olsen; Stephen B Beres; Matthew Ojeda Saavedra; Samantha L Kubiak; Concepcion C Cantu; Leslie Jenkins; Andrew S Waller; Zhizeng Sun; Timothy Palzkill; Adeline R Porter; Frank R DeLeo; James M Musser
Journal:  JCI Insight       Date:  2020-06-04

4.  A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development.

Authors:  Martina Sanderson-Smith; David M P De Oliveira; Julien Guglielmini; David J McMillan; Therese Vu; Jessica K Holien; Anna Henningham; Andrew C Steer; Debra E Bessen; James B Dale; Nigel Curtis; Bernard W Beall; Mark J Walker; Michael W Parker; Jonathan R Carapetis; Laurence Van Melderen; Kadaba S Sriprakash; Pierre R Smeesters
Journal:  J Infect Dis       Date:  2014-05-05       Impact factor: 5.226

5.  Murine model of recurrent group G streptococcal cellulitis: no evidence of protective immunity.

Authors:  A L Bisno; J M Gaviria
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

6.  Role of Mga in group A streptococcal infection at the skin epithelium.

Authors:  Feng Luo; Sergio Lizano; Sukalyani Banik; Hong Zhang; Debra E Bessen
Journal:  Microb Pathog       Date:  2008-06-07       Impact factor: 3.738

7.  Group A Streptococcus gene expression in humans and cynomolgus macaques with acute pharyngitis.

Authors:  Kimmo Virtaneva; Morag R Graham; Stephen F Porcella; Nancy P Hoe; Hua Su; Edward A Graviss; Tracie J Gardner; James E Allison; William J Lemon; John R Bailey; Michael J Parnell; James M Musser
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

8.  THE PROPERTIES OF T ANTIGENS EXTRACTED FROM GROUP A HEMOLYTIC STREPTOCOCCI.

Authors:  R C Lancefield; V P Dole
Journal:  J Exp Med       Date:  1946-10-31       Impact factor: 14.307

Review 9.  Modeling Streptococcus pyogenes Pharyngeal Colonization in the Mouse.

Authors:  Artemis Gogos; Michael J Federle
Journal:  Front Cell Infect Microbiol       Date:  2019-05-02       Impact factor: 5.293

10.  Persistence of type-specific antibodies in man following infection with group A streptococci.

Authors:  R C LANCEFIELD
Journal:  J Exp Med       Date:  1959-08-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.